Betamethasone butyrate propionate

Drug Profile

Betamethasone butyrate propionate

Alternative Names: Antebate; BBP; TO 186

Latest Information Update: 24 Jan 1995

Price : $50

At a glance

  • Originator Mitsubishi Chemical
  • Developer Mitsubishi Chemical; Torii Pharmaceutical
  • Class Analgesics; Anti-inflammatories; Antipruritics; Fluorinated steroids; Glucocorticoids; Small molecules
  • Mechanism of Action Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Psoriasis

Most Recent Events

  • 24 Jan 1995 Launched for Psoriasis in Japan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top